HC Wainwright Forecasts Transcat's Q2 Earnings (NASDAQ:TRNS)

Key Points

• HC Wainwright has raised its Q2 2026 earnings per share estimate for Transcat (NASDAQ:TRNS) from $0.43 to $0.48, maintaining a "Buy" rating with a target price of $116.00.
• Transcat recently reported a Q2 profit of $0.59 EPS, exceeding analysts' expectations, and had a revenue of $76.42 million, surpassing consensus estimates.
• Institutional investors hold 98.34% of Transcat's stock, indicating strong interest from large financial entities in the company.

Transcat, Inc. (NASDAQ:TRNS - Free Report) - Stock analysts at HC Wainwright raised their Q2 2026 earnings per share (EPS) estimates for Transcat in a report issued on Monday, August 11th. HC Wainwright analyst S. Buck now anticipates that the scientific and technical instruments company will post earnings of $0.48 per share for the quarter, up from their prior forecast of $0.43. HC Wainwright currently has a "Buy" rating and a $116.00 price objective on the stock. The consensus estimate for Transcat's current full-year earnings is $2.30 per share. HC Wainwright also issued estimates for Transcat's Q3 2026 earnings at $0.47 EPS and FY2027 earnings at $2.58 EPS.

Other equities research analysts have also issued reports about the company. Wall Street Zen upgraded Transcat from a "sell" rating to a "hold" rating in a research note on Wednesday, May 28th. Lake Street Capital began coverage on Transcat in a report on Thursday, July 10th. They issued a "buy" rating and a $105.00 target price on the stock. Three equities research analysts have rated the stock with a hold rating and three have issued a buy rating to the stock. According to data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and an average price target of $112.20.

Transcat Stock Performance

TRNS traded up $0.07 on Tuesday, hitting $81.54. 54,826 shares of the stock traded hands, compared to its average volume of 82,974. Transcat has a 52 week low of $67.56 and a 52 week high of $133.72. The company has a current ratio of 2.92, a quick ratio of 2.36 and a debt-to-equity ratio of 0.11. The firm has a market capitalization of $759.95 million, a PE ratio of 57.02 and a beta of 0.71. The business has a fifty day moving average price of $81.95 and a two-hundred day moving average price of $80.36.

Transcat (NASDAQ:TRNS - Get Free Report) last posted its quarterly earnings data on Wednesday, August 6th. The scientific and technical instruments company reported $0.59 earnings per share for the quarter, topping the consensus estimate of $0.40 by $0.19. Transcat had a return on equity of 6.66% and a net margin of 4.64%. The business had revenue of $76.42 million during the quarter, compared to analysts' expectations of $72.28 million.

Institutional Inflows and Outflows

A number of large investors have recently made changes to their positions in the stock. Tower Research Capital LLC TRC lifted its stake in shares of Transcat by 245.5% in the 2nd quarter. Tower Research Capital LLC TRC now owns 1,123 shares of the scientific and technical instruments company's stock valued at $97,000 after purchasing an additional 798 shares during the period. Lazard Asset Management LLC bought a new stake in shares of Transcat in the 2nd quarter valued at $54,000. Engineers Gate Manager LP bought a new stake in shares of Transcat in the 2nd quarter valued at $1,491,000. BNP Paribas Financial Markets increased its position in shares of Transcat by 1,315.9% in the 2nd quarter. BNP Paribas Financial Markets now owns 9,175 shares of the scientific and technical instruments company's stock valued at $789,000 after buying an additional 8,527 shares in the last quarter. Finally, Bamco Inc. NY increased its position in shares of Transcat by 8.9% in the 2nd quarter. Bamco Inc. NY now owns 167,713 shares of the scientific and technical instruments company's stock valued at $14,417,000 after buying an additional 13,689 shares in the last quarter. Institutional investors and hedge funds own 98.34% of the company's stock.

About Transcat

Transcat, Inc provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments: Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services.